Background The proteins S100B, neuron-specific enolase (NSE), glial fibrillary acidic
protein (GFAP), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), and neurofilament light …

Traumatic brain injury (TBI) is one of the world's leading causes of morbidity and mortality
among young individuals. TBI applies powerful rotational and translational forces to the …

Background In order to improve assessment and outcome prediction in patients suffering
from traumatic brain injury (TBI), cerebral protein levels in serum have been suggested as …

Rapid triage and decision‐making in the treatment of traumatic brain injury (TBI) present
challenging dilemma in “resource poor” environments such as the battlefield and developing …

Background Several studies have suggested that neuron-specific enolase (NSE) in serum
may be a biomarker of traumatic brain injury. However, whether serum NSE levels correlate …

Devastating brain injuries (DBIs) profoundly damage cerebral function and frequently cause
death. DBI survivors admitted to critical care will suffer both intracranial and extracranial …

Diffuse axonal injury (DAI), a type of traumatic injury, is known for its severe consequences.
However, there are few studies describing the outcomes of DAI and the risk factors …

Traumatic brain injury (TBI), defined as an alteration in brain functions caused by an external
force, is responsible for high morbidity and mortality around the world. It is important to …

Background: Traumatic brain injury results in some distinctive patterns of cognitive,
behavioural and physical impairment which impact significantly on independent living skills …

Background Blood biomarkers are valuable tools for elucidating complex cellular and
molecular mechanisms underlying traumatic brain injury (TBI). Profiling distinct classes of …